A citation-based method for searching scientific literature

Wenbin Li, Yunfeng Lyu, Shaoming Wang, Xiaoyan Zhou, Jie Ma, Chao Xu, Li Fang, Jianming Ying. JTO Clin Res Rep 2021
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers.
S Savic, C Tapia, B Grilli, A Rufle, M P Bihl, A de Vito Barascud, M Herzog, L Terracciano, F Baty, L Bubendorf. Br J Cancer 2008
84
50

Coexistence of EGFR with KRAS, or BRAF, or PIK3CA somatic mutations in lung cancer: a comprehensive mutation profiling from 5125 Chinese cohorts.
S Li, L Li, Y Zhu, C Huang, Y Qin, H Liu, L Ren-Heidenreich, B Shi, H Ren, X Chu,[...]. Br J Cancer 2014
151
50

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer.
Darren A E Cross, Susan E Ashton, Serban Ghiorghiu, Cath Eberlein, Caroline A Nebhan, Paula J Spitzler, Jonathon P Orme, M Raymond V Finlay, Richard A Ward, Martine J Mellor,[...]. Cancer Discov 2014
50


Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology.
Neal I Lindeman, Philip T Cagle, Mary Beth Beasley, Dhananjay Arun Chitale, Sanja Dacic, Giuseppe Giaccone, Robert Brian Jenkins, David J Kwiatkowski, Juan-Sebastian Saldivar, Jeremy Squire,[...]. J Thorac Oncol 2013
577
50

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
50

EGFR, KRAS, BRAF and HER2 testing in metastatic lung adenocarcinoma: Value of testing on samples with poor specimen adequacy and analysis of discrepancies.
Fabien Forest, Marie-Laure Stachowicz, François Casteillo, Georgia Karpathiou, Fabienne Gouzy-Grosjean, Colette Guilaubey, Michèle Cottier, Julie Beal, Alix Clemenson, Michel Péoc'h. Exp Mol Pathol 2017
17
50

Rare EGFR exon 18 and exon 20 mutations in non-small-cell lung cancer on 10 117 patients: a multicentre observational study by the French ERMETIC-IFCT network.
M Beau-Faller, N Prim, A-M Ruppert, I Nanni-Metéllus, R Lacave, L Lacroix, F Escande, S Lizard, J-L Pretet, I Rouquette,[...]. Ann Oncol 2014
203
50

Survival past five years with advanced, EGFR-mutated or ALK-rearranged non-small cell lung cancer-is there a "tail plateau" in the survival curve of these patients?
Shoko Sonobe Shimamura, Takehito Shukuya, Tetsuhiko Asao, Daisuke Hayakawa, Kana Kurokawa, Shiting Xu, Keita Miura, Yoichiro Mitsuishi, Ken Tajima, Rina Shibayama,[...]. BMC Cancer 2022
1
100

EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis.
Vladimir Jurisic, Vladimir Vukovic, Jasmina Obradovic, Lyudmila F Gulyaeva, Nikolay E Kushlinskii, Nataša Djordjević. J Oncol 2020
21
50

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.
Evgeny N Imyanitov, Aglaya G Iyevleva, Evgeny V Levchenko. Crit Rev Oncol Hematol 2021
85
50

Incidence of EGFR exon 19 deletions and L858R in tumor specimens from men and cigarette smokers with lung adenocarcinomas.
Sandra P D'Angelo, M Catherine Pietanza, Melissa L Johnson, Gregory J Riely, Vincent A Miller, Camelia S Sima, Maureen F Zakowski, Valerie W Rusch, Marc Ladanyi, Mark G Kris. J Clin Oncol 2011
184
50

A comparison of epidermal growth factor receptor mutation testing methods in different tissue types in non-small cell lung cancer.
Suqin Yi, Yuan Zhuang, Jun Zhou, Haitao Ma, Jianan Huang, Lin Wang, Weidong Zhu, Suya Kang, Linchuan Guo, Feng Guo. Int J Mol Med 2014
13
50


Evaluation of 2-year experience with EGFR mutation analysis of small diagnostic samples.
Katarina Hlinkova, Pavel Babal, Peter Berzinec, Ivan Majer, Zdenka Mikle-Barathova, Barbora Piackova, Denisa Ilencikova. Diagn Mol Pathol 2013
15
50

Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care.
Kenneth P H Pritzker, Heikki J Nieminen. Arch Pathol Lab Med 2019
22
50



Making the first move in EGFR-driven or ALK-driven NSCLC: first-generation or next-generation TKI?
Gonzalo Recondo, Francesco Facchinetti, Ken A Olaussen, Benjamin Besse, Luc Friboulet. Nat Rev Clin Oncol 2018
175
50

Sample features associated with success rates in population-based EGFR mutation testing.
Carolyn J Shiau, Jesse P Babwah, Gilda da Cunha Santos, Jenna R Sykes, Scott L Boerner, William R Geddie, Natasha B Leighl, Cuihong Wei, Suzanne Kamel-Reid, David M Hwang,[...]. J Thorac Oncol 2014
51
50

Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib.
David M Jackman, Beow Y Yeap, Lecia V Sequist, Neal Lindeman, Alison J Holmes, Victoria A Joshi, Daphne W Bell, Mark S Huberman, Balazs Halmos, Michael S Rabin,[...]. Clin Cancer Res 2006
455
50

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.
Florian Kocher, Wolfgang Hilbe, Andreas Seeber, Andreas Pircher, Thomas Schmid, Richard Greil, Jutta Auberger, Meinhard Nevinny-Stickel, William Sterlacci, Alexandar Tzankov,[...]. Lung Cancer 2015
65
50

HER2 exon 20 insertions in non-small-cell lung cancer are sensitive to the irreversible pan-HER receptor tyrosine kinase inhibitor pyrotinib.
Y Wang, T Jiang, Z Qin, J Jiang, Q Wang, S Yang, C Rivard, G Gao, T L Ng, M M Tu,[...]. Ann Oncol 2019
104
50

EGFR mutations and tumor metastases in patients with nonsmall cell lung cancer in the South of Russia.
Oleg I Kit, Dmitry I Vodolazhsky, Natalia N Timoshkina, Lubov' Yu Vladimirova, Igor N Turkin, Ksenia A Kutsyn, Yaroslav S Enin, Svetlana B Panina, Vladimir Jurisic. J BUON 2017
5
50

A proposal for cellularity assessment for EGFR mutational analysis with a correlation with DNA yield and evaluation of the number of sections obtained from cell blocks for immunohistochemistry in non-small cell lung carcinoma.
Gilda da Cunha Santos, Tyler Wyeth, Allie Reid, Mauro Ajaj Saieg, Bethany Pitcher, Melania Pintilie, Suzanne Kamel-Reid, Ming Sound Tsao. J Clin Pathol 2016
13
50


The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.
Cai-Hong Yun, Kristen E Mengwasser, Angela V Toms, Michele S Woo, Heidi Greulich, Kwok-Kin Wong, Matthew Meyerson, Michael J Eck. Proc Natl Acad Sci U S A 2008
50

EGFR mutation testing in pulmonary adenocarcinoma: evaluation of tumor cell number and tumor percent in paraffin sections of 120 small biopsies.
Stefania Scarpino, Federica Pulcini, Arianna Di Napoli, Maria Giubettini, Luigi Ruco. Lung Cancer 2015
11
50

Somatic mutation analysis of EGFR, KRAS, BRAF and PIK3CA in 861 patients with non-small cell lung cancer.
Jianping Xu, Jiaying He, Huiyi Yang, Xiaodi Luo, Zhangmin Liang, Jiaxin Chen, Zhiping Cai, Jiasen Xu, Lifen Ren-Heidenreich. Cancer Biomark 2011
37
50

Epidermal growth factor receptor gene analysis with a highly sensitive molecular assay in routine cytologic specimens of lung adenocarcinoma.
Sara Allegrini, Jlenia Antona, Rosanna Mezzapelle, Umberto Miglio, Alessia Paganotti, Claudia Veggiani, Milo Frattini, Guido Monga, Piero Balbo, Renzo Boldorini. Am J Clin Pathol 2012
39
50

A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).
Yuankai Shi, Joseph Siu-Kie Au, Sumitra Thongprasert, Sankar Srinivasan, Chun-Ming Tsai, Mai Trong Khoa, Karin Heeroma, Yohji Itoh, Gerardo Cornelio, Pan-Chyr Yang. J Thorac Oncol 2014
792
50

Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
Masahiro Fukuoka, Yi-Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan-Swan Leong, Virote Sriuranpong, Tsu-Yi Chao, Kazuhiko Nakagawa, Da-Tong Chu, Nagahiro Saijo,[...]. J Clin Oncol 2011
50

Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop.
Robert Pirker, Felix J F Herth, Keith M Kerr, Martin Filipits, Miquel Taron, David Gandara, Fred R Hirsch, Dominique Grunenwald, Helmut Popper, Egbert Smit,[...]. J Thorac Oncol 2010
211
50

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.
Xiang Chen, Armita Bahrami, Alberto Pappo, John Easton, James Dalton, Erin Hedlund, David Ellison, Sheila Shurtleff, Gang Wu, Lei Wei,[...]. Cell Rep 2014
411
50

Implementation of next generation sequencing into pediatric hematology-oncology practice: moving beyond actionable alterations.
Jennifer A Oberg, Julia L Glade Bender, Maria Luisa Sulis, Danielle Pendrick, Anthony N Sireci, Susan J Hsiao, Andrew T Turk, Filemon S Dela Cruz, Hanina Hibshoosh, Helen Remotti,[...]. Genome Med 2016
95
50

Larotrectinib for the treatment of TRK fusion solid tumors.
Theodore W Laetsch, Douglas S Hawkins. Expert Rev Anticancer Ther 2019
19
50

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases.
Ying-Nan P Chen, Matthew J LaMarche, Ho Man Chan, Peter Fekkes, Jorge Garcia-Fortanet, Michael G Acker, Brandon Antonakos, Christine Hiu-Tung Chen, Zhouliang Chen, Vesselina G Cooke,[...]. Nature 2016
429
50


Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
D Williams Parsons, Angshumoy Roy, Yaping Yang, Tao Wang, Sarah Scollon, Katie Bergstrom, Robin A Kerstein, Stephanie Gutierrez, Andrea K Petersen, Abhishek Bavle,[...]. JAMA Oncol 2016
269
50

Multicenter Feasibility Study of Tumor Molecular Profiling to Inform Therapeutic Decisions in Advanced Pediatric Solid Tumors: The Individualized Cancer Therapy (iCat) Study.
Marian H Harris, Steven G DuBois, Julia L Glade Bender, AeRang Kim, Brian D Crompton, Erin Parker, Ian P Dumont, Andrew L Hong, Dongjing Guo, Alanna Church,[...]. JAMA Oncol 2016
128
50

Actionable Tumor Alterations and Treatment Protocol Enrollment of Pediatric and Young Adult Patients With Refractory Cancers in the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial.
D Williams Parsons, Katherine A Janeway, David R Patton, Cynthia L Winter, Brent Coffey, P Mickey Williams, Sinchita Roy-Chowdhuri, Gregory J Tsongalis, Mark Routbort, Nilsa C Ramirez,[...]. J Clin Oncol 2022
1
100

Institutional implementation of clinical tumor profiling on an unselected cancer population.
Lynette M Sholl, Khanh Do, Priyanka Shivdasani, Ethan Cerami, Adrian M Dubuc, Frank C Kuo, Elizabeth P Garcia, Yonghui Jia, Phani Davineni, Ryan P Abo,[...]. JCI Insight 2016
260
50

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.
Elizabeth P Garcia, Alissa Minkovsky, Yonghui Jia, Matthew D Ducar, Priyanka Shivdasani, Xin Gong, Azra H Ligon, Lynette M Sholl, Frank C Kuo, Laura E MacConaill,[...]. Arch Pathol Lab Med 2017
226
50

Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
622
50

Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
Alexander Drilon, Theodore W Laetsch, Shivaani Kummar, Steven G DuBois, Ulrik N Lassen, George D Demetri, Michael Nathenson, Robert C Doebele, Anna F Farago, Alberto S Pappo,[...]. N Engl J Med 2018
50

Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor.
Matthew R Janes, Jingchuan Zhang, Lian-Sheng Li, Rasmus Hansen, Ulf Peters, Xin Guo, Yuching Chen, Anjali Babbar, Sarah J Firdaus, Levan Darjania,[...]. Cell 2018
536
50

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.
Dung T Le, Jennifer N Durham, Kellie N Smith, Hao Wang, Bjarne R Bartlett, Laveet K Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon S Luber,[...]. Science 2017
50

Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing.
Jonathan A Nowak, Matthew B Yurgelun, Jacqueline L Bruce, Vanesa Rojas-Rudilla, Dimity L Hall, Priyanka Shivdasani, Elizabeth P Garcia, Agoston T Agoston, Amitabh Srivastava, Shuji Ogino,[...]. J Mol Diagn 2017
103
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.